Skip to main content

Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes

  • Book
  • © 2008

Overview

  • The first contributed volume to feature the recent developments which solely involve the pharmacological and biomaterials applications as well as the chemical properties of fullerenes

Part of the book series: Carbon Materials: Chemistry and Physics (CMCP, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

Keywords

About this book

Fullerenes and nanotubes are two classes of carbon structures or allotropes, which were discovered about 17 years ago. Since that time, many chemical derivatives have been synthesized using fullerenes and nanotubes as building blocks.

Particularly promising was the theory that the chemical properties of fullerenes, and certain derivatives, made them likely candidates for anticancer drugs, inhibitors of viruses such as HIV, or even as anti-bacterials. Their cyctotoxicity can also be controlled by specific circumstances.

In addition, the funtionalization of nanotubes has not only produced relatively simple derivatives, but also complex hybrids with biological macromolecules, which show unique supramolecular architecture and which are promising in many medical applications.

The application of fullerenes and nanotubes in medicine is at the frontier of our knowledge, thus the work in this field represents the basis for future novel developments.

Editors and Affiliations

  • Lupi Chemical Research Institute, Rome, Italy

    Franco Cataldo

  • Dipartimento di Scienze Farmaceutiche, University of Trieste, Trieste, Italy

    Tatiana Ros

Bibliographic Information

Publish with us